Article

Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple negative breast cancer

2023-08-23

Abstract excerpt

<h4>Background: </h4> Triple-negative breast cancer (TNBC) has high heterogeneity, poor prognosis, and limited treatment success. Recently, an immunohistochemistry (IHC)-based surrogate classification for the “Fudan University Shanghai Cancer Center (FUSCC) subtyping” has been developed and is considered more suitable for clinical application. Here, the genetics and potential therapeutic targets for TNBC molecular...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7643f447-9059-50b4-b6da-d933e965b6eb
DOI: 10.21203/rs.3.rs-3271476/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple negative breast cancerDOI 10.21203/rs.3.rs-3271476/v1Read

Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer.Semantic proximity Read

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity Read

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.Semantic proximity Read

A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypesSemantic proximity Read

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Semantic proximity Read

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read

Triple Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant ChemotherapySemantic proximity Read

Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity Read

Molecular subtypes and precision treatment of triple-negative breast cancerSemantic proximity Read

Molecular subtypes of triple-negative breast cancer: understanding of subtype categories and clinical implication.Semantic proximity Read

A large collection of integrated genomically characterized patient‐derived xenografts highlighting the heterogeneity of triple‐negative breast cancerSemantic proximity Read